| 注册
首页|期刊导航|肿瘤药学|CD19 CAR-T细胞治疗老年复发难治性套细胞淋巴瘤合并慢性肾脏病患者1例及文献复习

CD19 CAR-T细胞治疗老年复发难治性套细胞淋巴瘤合并慢性肾脏病患者1例及文献复习

周亦星 刘俊 李启英 刘耀

肿瘤药学2025,Vol.15Issue(3):329-336,8.
肿瘤药学2025,Vol.15Issue(3):329-336,8.DOI:10.3969/j.issn.2095-1264.2025.03.05

CD19 CAR-T细胞治疗老年复发难治性套细胞淋巴瘤合并慢性肾脏病患者1例及文献复习

CD19 CAR-T therapy for an elderly patient with relapsed/refractory mantle cell lymphoma and chronic kidney disease:a case report and literature review

周亦星 1刘俊 1李启英 1刘耀1

作者信息

  • 1. 重庆大学附属肿瘤医院,重庆,400030
  • 折叠

摘要

Abstract

Mantle cell lymphoma(MCL)is a special subtype of non Hodgkin's B-cell lymphoma,characterized by both invasiveness and inertness.This article reports a case of a patient with relapsed/refractory MCL complicated with chronic kidney disease(CKD).The patient achieved complete remission after receiving CD19-targeted chimeric antigen receptor T-cell(CAR-T)immunotherapy.Through clinical analysis of the case and systematic literature review,the study aims to provide evidence-based medical support for personalized comprehensive treatment strategies for relapsed/refractory MCL.

关键词

套细胞淋巴瘤/CAR-T/慢性肾脏病/肾功能不全

Key words

Mantle cell lymphoma/CAR-T/Chronic kidney disease/Renal insufficiency

分类

医药卫生

引用本文复制引用

周亦星,刘俊,李启英,刘耀..CD19 CAR-T细胞治疗老年复发难治性套细胞淋巴瘤合并慢性肾脏病患者1例及文献复习[J].肿瘤药学,2025,15(3):329-336,8.

肿瘤药学

2095-1264

访问量0
|
下载量0
段落导航相关论文